Aurobindo Pharma Usa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUROBINDO PHARMA USA
AUROBINDO PHARMA USA has sixty-eight approved drugs.
There are two tentative approvals on AUROBINDO PHARMA USA drugs.
Summary for Aurobindo Pharma Usa
| US Patents: | 0 |
| Tradenames: | 58 |
| Ingredients: | 57 |
| NDAs: | 68 |
| Patent Litigation for Aurobindo Pharma Usa: | See patent lawsuits for Aurobindo Pharma Usa |
| PTAB Cases with Aurobindo Pharma Usa as petitioner: | See PTAB cases with Aurobindo Pharma Usa as petitioner |
Drugs and US Patents for Aurobindo Pharma Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | EZETIMIBE AND SIMVASTATIN | ezetimibe; simvastatin | TABLET;ORAL | 200082-003 | Dec 17, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma Usa | RASAGILINE MESYLATE | rasagiline mesylate | TABLET;ORAL | 201971-001 | May 15, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma Usa | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET, DELAYED RELEASE;ORAL | 091052-001 | Feb 8, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Aurobindo Pharma Usa | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076129-004 | Sep 16, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Aurobindo Pharma Usa | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 090942-001 | Jul 14, 2010 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Aurobindo Pharma Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | ⤷ Start Trial |
| Aurobindo Pharma Usa | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | ⤷ Start Trial |
| Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
